{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T11:52:00Z","timestamp":1703591520252},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00292-018-0561-4","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T08:02:47Z","timestamp":1547798567000},"page":"7-12","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Plattenepitheliale Pr\u00e4kanzerosen der Cervix uteri"],"prefix":"10.1007","volume":"40","author":[{"given":"D.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,18]]},"reference":[{"key":"561_CR1","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S1470-2045(17)30700-3","volume":"18","author":"M Arbyn","year":"2017","unstructured":"Arbyn M, Redman C, Verdoodt F et al (2017) Incomplete excision of cervical precancer as a\u00a0predictor of treatment failure: a\u00a0systematic review and meta-analysis. Lancet Oncol 18:1665\u20131679. https:\/\/doi.org\/10.1016\/S1470-2045(17)30700-3","journal-title":"Lancet Oncol"},{"key":"561_CR2","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1097\/PAS.0000000000000498","volume":"39","author":"R Baars van","year":"2015","unstructured":"van Baars R, Griffin H, Wu Z et al (2015) Investigating diagnostic problems of CIN1 and CIN2 associated with high-risk HPV by combining the novel molecular biomarker panHPVE4 with P16INK4a. Am J Surg Pathol 39:1518. https:\/\/doi.org\/10.1097\/PAS.0000000000000498","journal-title":"Am J Surg Pathol"},{"key":"561_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1309\/AJCPXSVCDZ3D5MZM","volume":"133","author":"C Bergeron","year":"2010","unstructured":"Bergeron C, Ordi J, Schmidt D et al (2010) Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. Am J Clin Pathol 133:395\u2013406. https:\/\/doi.org\/10.1309\/AJCPXSVCDZ3D5MZM","journal-title":"Am J Clin Pathol"},{"key":"561_CR4","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1097\/pas.0b013e318058a544","volume":"31","author":"B Cai","year":"2007","unstructured":"Cai B, Ronnett BM, Stoler M et\u00a0al (2007) Longitudinal evaluation of interobserver and intraobserver agreement of cervical intraepithelial neoplasia diagnosis among an experienced panel of gynecologic pathologists. Am J Surg Pathol 31:1854. https:\/\/doi.org\/10.1097\/pas.0b013e318058a544","journal-title":"Am J Surg Pathol"},{"key":"561_CR5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/B978-0-323-44732-4.00013-3","volume-title":"Diagnostic gynecologic and obstretic pathology","author":"CP Crum","year":"2018","unstructured":"Crum CP, Meserve EE, Peters WA III (2018) Cervical squamous neoplasia. In: Diagnostic gynecologic and obstretic pathology, 3.\u00a0Aufl. Elsevier, Amsterdam, S\u00a0298\u2013374","edition":"3"},{"key":"561_CR6","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","volume":"136","author":"T Darragh","year":"2012","unstructured":"Darragh T, Colgan TJ, Cox TJ et al (2012) The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med 136:1266\u20131297. https:\/\/doi.org\/10.5858\/arpa.LGT200570","journal-title":"Arch. Pathol. Lab. Med."},{"key":"561_CR7","volume-title":"Krebs\u202fin\u202fDeutschland\u00a0f\u00fcr 2013\/2014","author":"Die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.\u202fV. RKI","year":"2017","unstructured":"Die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.\u202fV. RKI (2017) Krebs\u202fin\u202fDeutschland\u00a0f\u00fcr 2013\/2014 (11.\u202fAusg.)"},{"key":"561_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","volume":"320","author":"PU Force","year":"2018","unstructured":"Force PU, Curry SJ, Krist AH et\u00a0al (2018) Screening for cervical cancer: US preventive services task force recommendation statement. JAMA 320:674\u2013686. https:\/\/doi.org\/10.1001\/jama.2018.10897","journal-title":"JAMA"},{"key":"561_CR9","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/PAS.0b013e3181e8b2c4","volume":"34","author":"MT Galgano","year":"2010","unstructured":"Galgano MT, Castle PE, Atkins KA et\u00a0al (2010) Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 34:1077\u20131087. https:\/\/doi.org\/10.1097\/PAS.0b013e3181e8b2c4","journal-title":"Am J Surg Pathol"},{"key":"561_CR10","unstructured":"G-BA 2018-11-22 Beschluss des Gemeinsamen Bundesausschusses \u00fcber eine \u00c4nderung der Krebsfr\u00fcherkennungs-Richtlinie und eine \u00c4nderung der Richtlinie f\u00fcr organisierte Krebsfr\u00fcherkennungsprogramme: Programm zur Fr\u00fcherkennung von Zervixkarzinomen"},{"key":"561_CR11","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/PAS.0b013e3182989ee2","volume":"37","author":"M Herfs","year":"2013","unstructured":"Herfs M, Parra-Herran C, Howitt BE et al (2013) Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions. Am J Surg Pathol 37:1311\u20131318. https:\/\/doi.org\/10.1097\/PAS.0b013e3182989ee2","journal-title":"Am J Surg Pathol"},{"key":"561_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00292-016-0232-2","volume":"37","author":"Horn L\u2011CC","year":"2016","unstructured":"Horn L\u2011C, Brambs C, Handzel R et al (2016) Cervical cancer\u202f: Update on morphology. Pathologe 37:542\u2013548. https:\/\/doi.org\/10.1007\/s00292-016-0232-2","journal-title":"Pathologe"},{"key":"561_CR13","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1038\/modpathol.2016.141","volume":"29","author":"EC Huang","year":"2016","unstructured":"Huang EC, Tomic MM, Hanamornroongruang S et al (2016) p16ink4 and cytokeratin 7 immunostaining in predicting HSIL outcome for low-grade squamous intraepithelial lesions: a\u00a0case series, literature review and commentary. Mod Pathol 29:1501\u20131510. https:\/\/doi.org\/10.1038\/modpathol.2016.141","journal-title":"Mod Pathol"},{"key":"561_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pvr.2015.06.006","volume":"1","author":"L Karsa von","year":"2015","unstructured":"von Karsa L, Arbyn M, Vuyst H et\u00a0al (2015) European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination. Papillomavirus Res 1:22\u201331. https:\/\/doi.org\/10.1016\/j.pvr.2015.06.006","journal-title":"Papillomavirus Res"},{"key":"561_CR15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00292-016-0247-8","volume":"37","author":"S Lax","year":"2016","unstructured":"Lax SF, Horn L\u2011C, L\u00f6ning T (2016) Categorization of uterine cervix tumors\u202f: what\u2019s new in the 2014 WHO classification. Pathologe 37:573\u2013584. https:\/\/doi.org\/10.1007\/s00292-016-0247-8","journal-title":"Pathologe"},{"key":"561_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00292-015-0120-1","volume":"37","author":"K Marquardt","year":"2016","unstructured":"Marquardt K, Stubbe M, Broschewitz U (2016) Zervixkarzinome in Mecklenburg-Vorpommern. Pathologe 37:78\u201383. https:\/\/doi.org\/10.1007\/s00292-015-0120-1","journal-title":"Pathologe"},{"key":"561_CR17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/pas.0000000000000548","volume":"40","author":"C Paquette","year":"2016","unstructured":"Paquette C, Mills AM, Stoler MH (2016) Predictive value of cytokeratin 7 immunohistochemistry in cervical low-grade squamous intraepithelial lesion as a marker for risk of progression to a high-grade lesion. Am J Surg Pathol 40:236\u2013243. https:\/\/doi.org\/10.1097\/pas.0000000000000548","journal-title":"Am J Surg Pathol"},{"key":"561_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00428-018-2372-7","volume":"473","author":"MR Raspollini","year":"2018","unstructured":"Raspollini MR, Lax SF, McCluggage W (2018) The central role of the pathologist in the management of patients with cervical cancer: ESGO\/ESTRO\/ESP guidelines. Virchows Arch 473:45\u201354. https:\/\/doi.org\/10.1007\/s00428-018-2372-7","journal-title":"Virchows Arch"},{"key":"561_CR19","first-page":"301","volume":"8","author":"M Richart","year":"1973","unstructured":"Richart M (1973) Cervical intraepithelial neoplasia. Pathol Annu 8:301\u2013328","journal-title":"Pathol Annu"},{"key":"561_CR20","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s00292-016-0231-3","volume":"37","author":"D Schmidt","year":"2016","unstructured":"Schmidt D (2016) Moderne Biomarker bei Pr\u00e4kanzerosen der Cervix uteri. Pathologe 37:534\u2013541. https:\/\/doi.org\/10.1007\/s00292-016-0231-3","journal-title":"Pathologe"},{"key":"561_CR21","doi-asserted-by":"publisher","first-page":"k499","DOI":"10.1136\/bmj.k499","volume":"360","author":"K Tainio","year":"2018","unstructured":"Tainio K, Athanasiou A, Tikkinen KA et al (2018) Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ 360:k499. https:\/\/doi.org\/10.1136\/bmj.k499","journal-title":"BMJ"},{"key":"561_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/pas.0000000000001032","volume":"42","author":"B Umphress","year":"2018","unstructured":"Umphress B, Sanchez B, Paintal A et\u00a0al (2018) Utility of CK7 Versus p16 as a\u00a0Prognostic Biomarker in CIN 2. Am J Surg Pathol 42:479. https:\/\/doi.org\/10.1097\/pas.0000000000001032","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-018-0561-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-018-0561-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-018-0561-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T21:54:12Z","timestamp":1606082052000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-018-0561-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,18]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["561"],"URL":"https:\/\/doi.org\/10.1007\/s00292-018-0561-4","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,18]]},"assertion":[{"value":"18 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.\u00a0Schmidt erh\u00e4lt Vortragshonorare und Reisekostenunterst\u00fctzung von der Fa. Roche Diagnostics, Mannheim.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. Die Untersuchungen erfolgten unter Einhaltung der Vorgaben der Zentralen Ethikkommission der Bundes\u00e4rztekammer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}